These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22528555)

  • 21. Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction.
    Gronda E; Seravalle G; Trevano FQ; Costantino G; Casini A; Alsheraei A; Lovett EG; Vanoli E; Mancia G; Grassi G
    J Hypertens; 2015 Aug; 33(8):1704-8. PubMed ID: 26132760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central exogenous nitric oxide decreases cardiac sympathetic drive and improves baroreflex control of heart rate in ovine heart failure.
    Ramchandra R; Hood SG; May CN
    Am J Physiol Regul Integr Comp Physiol; 2014 Aug; 307(3):R271-80. PubMed ID: 24848361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.
    Halbach M; Abraham WT; Butter C; Ducharme A; Klug D; Little WC; Reuter H; Schafer JE; Senni M; Swarup V; Wachter R; Weaver FA; Wilks SJ; Zile MR; Müller-Ehmsen J
    Int J Cardiol; 2018 Sep; 266():187-192. PubMed ID: 29705650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of ganglionated plexus attenuates cardiac neural remodeling and heart failure progression in a canine model of acute heart failure post-myocardial infarction.
    Luo D; Hu H; Qin Z; Liu S; Yu X; Ma R; He W; Xie J; Lu Z; He B; Jiang H
    Auton Neurosci; 2017 Dec; 208():73-79. PubMed ID: 28941985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baroreflex activation therapy: a new treatment option for heart failure with reduced ejection fraction.
    Halbach M; Hickethier T; Madershahian N; Müller-Ehmsen J
    Expert Rev Cardiovasc Ther; 2014 Dec; 12(12):1465-9. PubMed ID: 25382103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Baroreflex activation therapy. A novel interventional approach to treat heart failure with reduced ejection fraction].
    Halbach M; Fritz T; Madershahian N; Pfister R; Reuter H
    Herz; 2015 Nov; 40(7):959-65. PubMed ID: 26525523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac contractility modulation with the impulse dynamics signal: studies in dogs with chronic heart failure.
    Sabbah HN; Haddad W; Mika Y; Nass O; Aviv R; Sharov VG; Maltsev V; Felzen B; Undrovinas AI; Goldstein S; Darvish N; Ben-Haim SA
    Heart Fail Rev; 2001 Jan; 6(1):45-53. PubMed ID: 11248767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early autonomic and repolarization abnormalities contribute to lethal arrhythmias in chronic ischemic heart failure: characteristics of a novel heart failure model in dogs with postmyocardial infarction left ventricular dysfunction.
    Adamson PB; Vanoli E
    J Am Coll Cardiol; 2001 May; 37(6):1741-8. PubMed ID: 11345393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comment on "Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction".
    Oliveira M
    Rev Port Cardiol; 2015 Dec; 34(12):795-7. PubMed ID: 27099884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left atrial reverse remodeling in dogs with moderate and advanced heart failure treated with a passive mechanical containment device: an echocardiographic study.
    Zacà V; Brewer R; Khanal S; Imai M; Jiang A; Wang M; Goldstein S; Sabbah HN
    J Card Fail; 2007 May; 13(4):312-7. PubMed ID: 17517352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skeletal muscle electrical stimulation improves baroreflex sensitivity and heart rate variability in heart failure rats.
    Lazzarotto Rucatti A; Jaenisch RB; Rossato DD; Bonetto JH; Ferreira J; Xavier LL; Sonza A; Dal Lago P
    Auton Neurosci; 2015 Dec; 193():92-6. PubMed ID: 26433753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autonomic regulation therapy suppresses quantitative T-wave alternans and improves baroreflex sensitivity in patients with heart failure enrolled in the ANTHEM-HF study.
    Libbus I; Nearing BD; Amurthur B; KenKnight BH; Verrier RL
    Heart Rhythm; 2016 Mar; 13(3):721-8. PubMed ID: 26601770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global left ventricular remodeling with the Acorn Cardiac Support Device: hemodynamic and angiographic findings in dogs with heart failure.
    Sabbah HN
    Heart Fail Rev; 2005 Jun; 10(2):109-15. PubMed ID: 16258718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Caloric Restriction Improves Cardiac Function, Remodeling, Adrenergic Responsiveness, and Sympathetic Innervation in a Model of Postischemic Heart Failure.
    de Lucia C; Gambino G; Petraglia L; Elia A; Komici K; Femminella GD; D'Amico ML; Formisano R; Borghetti G; Liccardo D; Nolano M; Houser SR; Leosco D; Ferrara N; Koch WJ; Rengo G
    Circ Heart Fail; 2018 Mar; 11(3):e004153. PubMed ID: 29535114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany.
    Borisenko O; Müller-Ehmsen J; Lindenfeld J; Rafflenbeul E; Hamm C
    BMC Cardiovasc Disord; 2018 Aug; 18(1):163. PubMed ID: 30092774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of long-term therapy with bosentan on the progression of left ventricular dysfunction and remodeling in dogs with heart failure.
    Mishima T; Tanimura M; Suzuki G; Todor A; Sharov VG; Goldstein S; Sabbah HN
    J Am Coll Cardiol; 2000 Jan; 35(1):222-9. PubMed ID: 10636284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic heart failure: a disease of the brain.
    Singh RB; Hristova K; Fedacko J; El-Kilany G; Cornelissen G
    Heart Fail Rev; 2019 Mar; 24(2):301-307. PubMed ID: 30341700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of non-excitatory cardiac contractility modulation electric signals on the progression of heart failure in dogs.
    Morita H; Suzuki G; Haddad W; Mika Y; Tanhehco EJ; Goldstein S; Ben-Haim S; Sabbah HN
    Eur J Heart Fail; 2004 Mar; 6(2):145-50. PubMed ID: 14984721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF.
    Zile MR; Abraham WT; Lindenfeld J; Weaver FA; Zannad F; Graves T; Rogers T; Galle EG
    Am Heart J; 2018 Oct; 204():139-150. PubMed ID: 30118942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.